# Chewing Ticagrelor Versus Prasugrel in ST-elevation Myocardial Infarction - A Platelet Reactivity Study

> **NCT03016611** · PHASE4 · UNKNOWN · sponsor: **Sheba Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- Acute Coronary Syndrome
- STEMI

## Interventions

- **DRUG:** Chewing Ticagrelor LD
- **DRUG:** Chewing Prasugrel LD

## Key facts

- **NCT ID:** NCT03016611
- **Lead sponsor:** Sheba Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-02
- **Primary completion:** 2017-12
- **Final completion:** —
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2017-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03016611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03016611, "Chewing Ticagrelor Versus Prasugrel in ST-elevation Myocardial Infarction - A Platelet Reactivity Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03016611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*